Mozarc Medical

Mozarc Medical is a newly formed, private medical device company singularly dedicated to transforming kidney health technology. Backed by strategic heavyweights Medtronic (a global medtech leader) and DaVita (a leading kidney care provider), the company aims to create a comprehensive portfolio covering renal access, home dialysis, and acute therapies. With a patient-centered mission and a global leadership team in place, Mozarc is positioned to address significant unmet needs in the growing renal care market, though it faces the challenges of integrating legacy assets, navigating a competitive landscape, and executing on its innovation roadmap as a new entity.

Integrated portfolio focused on three pillars: Kidney Access Solutions (vascular and peritoneal access), Home Dialysis Technologies (peritoneal and hemodialysis systems for home use), and Advancements in Acute Therapies (e.g., CRRT). Aims to combine devices, digital connectivity, and support services.

Mozarc faces intense competition from established global leaders Fresenius Medical Care and Baxter International, who control the majority of the dialysis market with comprehensive portfolios. In the high-growth home segment, it will compete directly with Fresenius's NxStage (home hemodialysis) and Baxter's leading position in peritoneal dialysis.